Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 21, 2016; 22(47): 10440-10449
Published online Dec 21, 2016. doi: 10.3748/wjg.v22.i47.10440
Published online Dec 21, 2016. doi: 10.3748/wjg.v22.i47.10440
Table 1 The criteria of the classification of Helicobacter pylori infection
(1) Anti-H. pylori IgG | Endoscopic gastric mucosal atrophy | |
(2) RUT | ||
(3) Culture test | ||
Present infection | Positive at least one detection systems | |
Past infection | Negative with all of three detection systems | Positive for atrophy |
Non-infection | Negative with all of three detection systems | No atrophy |
Table 2 Characteristics of patients who received hemodialysis
Age (yr) | 68.8 ± 11.2 |
Male/female (n/n) | 68/40 |
Duration of hemodialysis (yr) | 8.7 ± 8.6 |
Body weight (kg) | 51.4 ± 11.4 |
Body mass index (kg/m2) | 20.2 ± 3.5 |
Albumin (g/dL) | 3.4 ± 0.4 |
Total cholesterol (mg/dL) | 159.5 ± 36.4 |
Cholinesterase (U/L) | 230.3 ± 87.2 |
Infection of H. pylori: non/past/present | 29/30/49 |
Acyl-ghrelin (fmol/mL) | 25.9 ± 19.8 |
Desacyl-ghrelin (fmol/mL) | 256.2 ± 158.4 |
Pepsinogen I (ng/mL) | 349.9 ± 294.5 |
Pepsinogen II (ng/mL) | 43.5 ± 32.3 |
Pepsinogen I/II ratio | 8.3 ± 4.7 |
Table 3 Relationship between Helicobacter pylori status and plasma ghrelin level
H. pylori status | Non-infection | Past infection | Present infection | P value |
Number | 29 | 30 | 49 | |
Male/female (n/n) | 19/10 | 22/8 | 27/22 | 0.275 |
Age (yr) | 67.9 ± 10.7 | 71.7 ± 11.3 | 67.6 ± 11.3 | 0.119 |
Body weight (kg) | 51.2 ± 12.1 | 49.0 ± 8.3 | 51.9 ± 12.4 | 0.468 |
BMI (kg/m2) | 19.9 ± 3.4 | 19.3 ± 2.3 | 21.0 ± 4.0 | 0.160 |
Albumin (g/dL) | 3.5 ± 0.3 | 3.5 ± 0.4 | 3.3 ± 0.4 | 0.156 |
Total cholesterol (mg/dL) | 167.5 ± 36.1 | 149.5 ± 29.0 | 161.5 ± 44.2 | 0.175 |
Cholinesterase (U/L) | 247.0 ± 109.3 | 228.5 ± 64.3 | 207.5 ± 75.3 | 0.310 |
Acyl-ghrelin (fmol/mL) | 39.4 ± 23.0 | 23.4 ± 19.9a | 19.5 ± 14.0a | < 0.001 |
Desacyl-ghrelin (fmol/mL) | 353.2 ± 190.2 | 234.9 ± 137.5a | 211.8 ± 124.2a | 0.001 |
Pepsinogen I (ng/mL) | 551.8 ± 319.2 | 286.5 ± 268.2a | 269.3 ± 238.0a | < 0.001 |
Pepsinogen II (ng/mL) | 46.4 ± 24.5 | 28.5 ± 17.4a | 51.0 ± 39.9 | 0.002 |
Pepsinogen I/II | 12.2 ± 4.5 | 9.3 ± 4.1a | 5.3 ± 2.9a | < 0.001 |
Table 4 Relationship between endoscopic gastric mucosal atrophy and plasma ghrelin level
Mucosal atrophy | Non-atrophy | Mild atrophy | Moderate atrophy | Severe atrophy | P value |
Number | 32 | 15 | 29 | 32 | |
Male/female (n/n) | 19/13 | 10/5 | 19/10 | 20/12 | 0.969 |
Age (yr) | 67.5 ± 11.8 | 64.5 ± 12.3 | 71.9 ± 10.9 | 69.3 ± 10.0 | 0.293 |
Body weight (kg) | 50.7 ± 12.0 | 53.6 ± 10.5 | 50.6 ± 11.4 | 51.5 ± 11.4 | 0.708 |
BMI (kg/m2) | 19.9 ± 3.4 | 20.3 ± 2.8 | 20.1 ± 3.6 | 20.6 ± 3.9 | 0.896 |
Albumin (g/dL) | 3.5 ± 0.3 | 3.5 ± 0.3 | 3.3 ± 0.4 | 3.4 ± 0.5 | 0.351 |
Total cholesterol (mg/dL) | 166.4 ± 34.8 | 159.9 ± 34.9 | 153.6 ± 37.5 | 151.4 ± 40.4 | 0.510 |
Cholinesterase (U/L) | 246.0 ± 104.3 | 250.5 ± 77.7 | 201.9 ± 59.3 | 218.6 ± 77.6 | 0.283 |
Acyl-ghrelin (fmol/mL) | 39.4 ± 22.2 | 24.5 ± 23.1a | 20.2 ± 14.9a | 18.3 ± 11.8a | < 0.001 |
Desacyl-ghrelin (fmol/mL) | 345.7 ± 183.7 | 276.1 ± 169.4 | 212.6 ± 129.4a | 196.8 ± 104.4a | < 0.001 |
Pepsinogen I (ng/mL) | 525.9 ± 316.6 | 461.9 ± 330.3 | 284.2 ± 207.3a | 181.0 ± 198.8a | < 0.001 |
Pepsinogen II (ng/mL) | 45.9 ± 23.8 | 49.3 ± 32.0 | 45.8 ± 40.8 | 36.3 ± 31.6 | 0.120 |
Pepsinogen I/II | 11.6 ± 4.7 | 10.0 ± 4.6 | 6.9 ± 3.4a | 5.3 ± 3.3a | < 0.001 |
- Citation: Ichikawa H, Sugimoto M, Sakao Y, Sahara S, Ohashi N, Kato A, Sugimoto K, Furuta T, Andoh A, Sakao T, Yasuda H. Relationship between ghrelin, Helicobacter pylori and gastric mucosal atrophy in hemodialysis patients. World J Gastroenterol 2016; 22(47): 10440-10449
- URL: https://www.wjgnet.com/1007-9327/full/v22/i47/10440.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i47.10440